cbdMD, Inc. (YCBD)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.35
- As of
Kresmion compiles this page from YCBD's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
cbdMD, Inc. (YCBD): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-02.
See the full YCBD dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for YCBD on one page. Preview it with sample data, then open it live with a free account.
Preview the YCBD dossierActive signals for YCBD
- lowEARNINGS_MISS
Q3-2026: EPS $-0.09 vs $-0.0306 estimate, -0.06 on a near-zero consensus
- mediumEARNINGS_MISS
Q2-2026: Missed consensus by 56.9% - EPS $-0.08 vs $-0.051 estimate
- lowEARNINGS_MISS
Q3-2025: EPS $-0.21 vs $-0.0204 estimate, -0.19 on a near-zero consensus
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 138.1% - EPS $-0.17 vs $-0.0714 estimate
- mediumEARNINGS_BEAT
Q1-2026: Beat consensus by 34.6% - EPS $-0.04 vs $-0.0612 estimate
FREE, NO ACCOUNT
Every signal on YCBD, as it fires
You are seeing 5 of 6 signals recorded on YCBD since 2026-05-17.
The five above landed across 3 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, YCBD
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
YCBD against its peers
YCBD's operating margin of -11.3% ranks in the 81st percentile of 12 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-05-31 and 2026-03-31.
| Metric | YCBD | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 19.2M USD | 1.5M USD | 73 | 12 |
| Revenue YoY | n/a | 12.5% | n/a | 6 |
| Gross margin | 62.4% | 38.0% | 79 | 11 |
| Operating margin | -11.3% | -83.1% | 81 | 12 |
| Net margin | -10.6% | -25.3% | 82 | 13 |
| Return on equity | -28.2% | -58.8% | 65 | 9 |
| 1 year | -72.3% | -50.0% | 35 | 9 |
Peers (16): SNOA, LVRLF, GELS, BUDZ, APUS, IMCC, PRFX, CVSI, CBIH, BTAI, SXTC, CABR, BIOE, BFRI, SBFM, HYEX. Left out: AKAN (period gap), PLSH (period gap), RDHL (period gap), CTTH (period gap), INM (period gap), PCYN (period gap), CANN (period gap), TRUFF (no annual filing), CNTMF (no annual filing). Fiscal periods ending between 2025-05-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (YCBD: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow YCBD on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to YCBD for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.